TGF alpha is dispensable for skin tumorigenesis in Tg.AC mice.
Alterations in growth factor signaling pathways frequently accompany the development and maintenance of epithelial neoplasia. Transforming growth factor alpha (TGF alpha) and its epidermal growth factor receptor have been thought to play an especially important role in epithelial neoplasia. In this study, mice were derived genetically deficient (null) in functional TGF alpha expression and carrying the Tg.AC/v-Ha-ras transgene. The goals were to determine if (a) papillomagenesis was dependent on TGF alpha and (b) progression to malignancy was dependent on TGF alpha expression. Groups of male and female mice heterozygous or homozygous for the TGF alpha null allele and hemizygous for the Tg.AC transgene were treated twice weekly for 10 or 15 wk with doses of 12-O-tetradecanoylphorbol-13-acetate (TPA) known to produce papillomas in Tg.AC mice. Papillomas were readily induced in both male and female TGF alpha null mice. Malignant progression of papillomas was observed in all TGF alpha null treatment groups. Additionally, we examined the response of TGF alpha null mice to full thickness dorsal wounds, a stimulus known to promote papillomagenesis in Tg.AC mice. As in the TPA study, papillomas were induced in both male and female TGF alpha null mice. These studies indicate that TGF alpha is not required for the induction and maintenance of papillomas nor is it essential for the malignant conversion of papillomas in Tg.AC mice.
Curriculum in Toxicology, University of North Carolina, Chapel Hill 27514, USA.
M C
MC
Humble
C J
CJ
Szczesniak
N C
NC
Luetteke
J W
JW
Spalding
R E
RE
Cannon
L A
LA
Hansen
D C
DC
Lee
R W
RW
Tennant
D000818:Animals; D002273:Carcinogens / Q000378:metabolism; D002277:Carcinoma / Q000139:chemically induced / Q000473:pathology*; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced / Q000473:pathology*; D066246:ErbB Receptors / Q000096:biosynthesis / Q000235:genetics; D005260:Female; D005838:Genotype; D051379:Mice; D008822:Mice, Transgenic; D010212:Papilloma / Q000139:chemically induced / Q000473:pathology*; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012878:Skin Neoplasms / Q000139:chemically induced / Q000473:pathology*; D016211:Transforming Growth Factor alpha / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D014945:Wound Healing
D002273:Carcinogens; D016211:Transforming Growth Factor alpha; D066246:ErbB Receptors